NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Bipolar Disorders


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Alkermes' Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference
2009 NOV 17 ... alcohol dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable, pulmonary ... for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has ...
Subject: Alkermes, Inc.
Price: $3.00
*
Alkermes' Corporate Presentation to be Webcast at the Lazard Capital Markets Healthcare Conference
2009 NOV 24 ... alcohol dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable, pulmonary ... for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has ...
Subject: Alkermes
Price: $3.00
*
First Lady Michelle Obama, Dr. Jill Biden Join Blue Star Families, This Emotional Life Producers to Support Military Families
2009 NOV 28 ... the National Alliance on Mental Illness, Mental Health America, the Depression and Bipolar Support Alliance and Mayo Clinic.Keywords: Asia, Defense, Military, ... Defense, Military, Pediatrics, Vietnam, Depression, Mental Health, Post-Traumatic Stress Disorders, Psychology, Wellness, Vulcan Productions.This article was prepared by ...
Subject: Vulcan Productions
Price: $3.00
*
Gene knockout may cheer up mice
2009 NOV 23 ... in open spaces". The causes of mood dysfunction, as seen in depressive and bipolar disorders, are still not fully understood. They are believed to be multifactorial, involving ...
Subject: BioMed Central
View Free
Daily News
Article
Insight Psychological Centers Joins Women's Health Practice In Willowbrook, Illinois
2009 NOV 9 ... provider of intensive group programming for eating disorders, depression, anxiety and bipolar disorder, will begin serving the Willowbrook area on November 1st. Insight ...
Subject: Anxiety Disorders
Price: $3.00
*
Less Than One-Third of Adults with Mental Illness Will Get Help In 2009
2009 NOV 16 ... individuals and their families. Mental illness includes major depression, bipolar disorder, schizophrenia, post-traumatic stress disorder (PTSD) and anxiety disorders. ...
Subject: Mental Illness
Price: $3.00
*
New anxiety disorders therapy research from University of Rio Grande discussed
2009 NOV 9 ... information, contact M. Kauer-Sant'Anna, Federal University of Rio Grande do Sul, Bipolar Disorders Program and Molecular Psychiatry Unit, INCT-Translational Medicine, Hospital de Clinicas ...
Subject: Anxiety Disorders Therapy
Price: $3.00
*
New bipolar disorder research from P.F. Bell et al outlined
2009 NOV 23 ... and increased availability of medication options have led to calls for treating bipolar disorders in the primary care setting. Second-generation antipsychotic medications (SGAs) were ...
Subject: Bipolar Disorder
Price: $3.00
*
New Higher Dose of Focalin XR(R) Improves Control of ADHD Symptoms for Up to 12 Hours
2009 NOV 16 ... in patients with psychotic disorders. Use with caution in patients with comorbid bipolar disorder. Treatment-emergent new psychotic or manic symptoms may occur without a prior ...
Subject: Pediatrics
Price: $3.00
*
New research on bipolar disorder from Yale University, Medical Department summarized
2009 NOV 16 ... inhibitors may be neuroprotective in disorders with dysregulated PKC signaling such as bipolar disorder, schizophrenia, post-traumatic stress disorder, and lead poisoning-conditions ...
Subject: Bipolar Disorder
Price: $3.00
*
Research from City University of New York yields new findings on bipolar disorder
2009 NOV 23 ... "Etiological commonalities are apparent between bipolar disorder and schizophrenia. For example, it is becoming clear that both populations show ... been established as an endophenotype in schizophrenia, a finding of commonality between disorders would raise the possibility that it represents a measure of common genetic liability. We ...
Subject: Bipolar Disorder
Price: $3.00
*
Research from M. Paino and co-authors in the area of depression published
2009 NOV 16 ... disorder (SAD), a DSM seasonal pattern specifier linked to major depression and bipolar disorder recurrent describing the course of illness during seasons," scientists in ... "Recent decades have seen significant advances in the knowledge of pathogenesis of mood disorders, as well as of other conditions directly or indirectly related to such diseases. Such ...
Subject: Depression
Price: $3.00
*
Researchers from Astellas Pharma, Inc. discuss findings in central nervous system disorders therapy
2009 NOV 23 ... mice,' is the subject of a report. "Valproic acid (VPA) is used to treat epilepsy and bipolar disorders, as well as for migraine prophylaxis. However, its clinical use is limited by two ...
Subject: Central Nervous System Disorders Therapy
View Free
Daily News
Article
Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
2009 NOV 16 ... Use with caution in patients with a history of: psychosis; EEG abnormalities; bipolar disorder; depression. Hematologic monitoring is advised during prolonged treatment. ... ADHD diagnostic criteria as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision=AE, a publication of the American Psychiatric ...
Subject: Tics
Price: $3.00
*
Studies from National Institute on Alcohol Abuse and Alcoholism reveal new findings on anxiety disorders risk factors
2009 NOV 9 ... substance use disorders and greater among women for mood and anxiety disorders except bipolar disorders and social phobia. Age was inversely related to all disorders. Black individuals were at ...
Subject: Anxiety Disorders Risk Factors
Price: $3.00
*
Study findings from S. Sharma et al broaden understanding of bipolar disorder
2009 NOV 16 ... Journal of Therapeutics (Therapeutic Drug Monitoring of Lithium in Patients With Bipolar Affective Disorder: Experiences From a Tertiary Care Hospital in India. American Journal ... According to a study from Delhi, India, "Lithium continues to be a main drug in mood disorders despite risks associated with high blood levels of lithium and introduction of a number ...
Subject: Bipolar Disorder
Price: $3.00
*
Use of antipsychotic medications by children and adolescents associated with significant weight gain
2009 NOV 9 ... a study in the October 28 issue of JAMA. Treatment for psychotic disorders, bipolar disorder, and nonpsychotic mental disorders for children and adolescents in the United ...
Subject: JAMA and Archives Journals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login